Psychiatric comorbidity and suicidal ideation in psoriasis, melanoma and allergic disorders

Maurizio Pompili, Marco Innamorati, Alberto Forte, Denise Erbuto, Dorian A. Lamis, Alessandra Narcisi, Claudia Rea, Diego Orsini, Andrea D’Arino, Annalisa Arcese, Samantha Bellini, Sara Trovarelli, Gianluca Serafini, Mario Amore, Antonio Costanzo, Paolo Girardi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

© 2017 Informa UK Limited, trading as Taylor & Francis Group. Objective: Psychiatric disorders and suicide risk (especially in psoriasis) are frequent and disabling conditions in patients with skin diseases. The aim of this study was to examine the risk of suicide and stressful life events in a sample of patients with skin disease. Methods: A sample of 242 dermatological patients (142 women and 100 men), 112 of which had psoriasis, 77 had melanoma, and 53 were suffering with chronic allergic diseases. Patients were administered the MINI International Neuropsychiatric Interview (MINI), Hamilton Depression Rating Scale (HDRS), Hamilton Anxiety Rating Scale (HARS), and the Columbia-Suicide Severity Rating Scale (C-SSRS). Patients were also asked about their experiences with stressful life events. Results: Patients with psoriasis were more likely to have a history of psychiatric disorders (36.6% vs. 13.2% χ 2 (1) = 9.55; p = 0.002) compared to patients with allergies. Specifically, patients with psoriasis more likely had a diagnosis of a mood disorder (16.1% vs. 3.9% χ 2 (1) = 6.85; p = 0.009; 16.1% vs. 0% χ 2 (1) = 9.56; p = 0.002) and reported past suicidal ideation (33.9% vs. 15.6% χ 2 (1) = 7.89; p = 0.005; 33.9% vs. 18.9% χ 2 (1) = 3.96; p = 0.047) as compared to those with melanoma and allergy. Conclusions: The results from this study suggest that patients affected by psoriasis have an increased risk of psychiatric comorbidities and suicidal ideation compared to those who have other dermatological disorders.
Original languageEnglish
Pages (from-to)209-214
Number of pages6
JournalInternational Journal of Psychiatry in Clinical Practice
Volume21
Issue number3
DOIs
Publication statusPublished - Jul 3 2017

Fingerprint

Suicidal Ideation
Psoriasis
Psychiatry
Comorbidity
Melanoma
Suicide
Skin Diseases
Hypersensitivity
Mood Disorders
Chronic Disease
Anxiety
Interviews
Depression

Keywords

  • anxiety
  • comorbidity
  • depression
  • dermatological disorders
  • Psoriasis
  • psychiatry
  • suicide risk

Cite this

Psychiatric comorbidity and suicidal ideation in psoriasis, melanoma and allergic disorders. / Pompili, Maurizio; Innamorati, Marco; Forte, Alberto; Erbuto, Denise; Lamis, Dorian A.; Narcisi, Alessandra; Rea, Claudia; Orsini, Diego; D’Arino, Andrea; Arcese, Annalisa; Bellini, Samantha; Trovarelli, Sara; Serafini, Gianluca; Amore, Mario; Costanzo, Antonio; Girardi, Paolo.

In: International Journal of Psychiatry in Clinical Practice, Vol. 21, No. 3, 03.07.2017, p. 209-214.

Research output: Contribution to journalArticle

Pompili, M, Innamorati, M, Forte, A, Erbuto, D, Lamis, DA, Narcisi, A, Rea, C, Orsini, D, D’Arino, A, Arcese, A, Bellini, S, Trovarelli, S, Serafini, G, Amore, M, Costanzo, A & Girardi, P 2017, 'Psychiatric comorbidity and suicidal ideation in psoriasis, melanoma and allergic disorders', International Journal of Psychiatry in Clinical Practice, vol. 21, no. 3, pp. 209-214. https://doi.org/10.1080/13651501.2017.1301482
Pompili, Maurizio ; Innamorati, Marco ; Forte, Alberto ; Erbuto, Denise ; Lamis, Dorian A. ; Narcisi, Alessandra ; Rea, Claudia ; Orsini, Diego ; D’Arino, Andrea ; Arcese, Annalisa ; Bellini, Samantha ; Trovarelli, Sara ; Serafini, Gianluca ; Amore, Mario ; Costanzo, Antonio ; Girardi, Paolo. / Psychiatric comorbidity and suicidal ideation in psoriasis, melanoma and allergic disorders. In: International Journal of Psychiatry in Clinical Practice. 2017 ; Vol. 21, No. 3. pp. 209-214.
@article{22a088bd98f84e7cb276258d44ba959f,
title = "Psychiatric comorbidity and suicidal ideation in psoriasis, melanoma and allergic disorders",
abstract = "{\circledC} 2017 Informa UK Limited, trading as Taylor & Francis Group. Objective: Psychiatric disorders and suicide risk (especially in psoriasis) are frequent and disabling conditions in patients with skin diseases. The aim of this study was to examine the risk of suicide and stressful life events in a sample of patients with skin disease. Methods: A sample of 242 dermatological patients (142 women and 100 men), 112 of which had psoriasis, 77 had melanoma, and 53 were suffering with chronic allergic diseases. Patients were administered the MINI International Neuropsychiatric Interview (MINI), Hamilton Depression Rating Scale (HDRS), Hamilton Anxiety Rating Scale (HARS), and the Columbia-Suicide Severity Rating Scale (C-SSRS). Patients were also asked about their experiences with stressful life events. Results: Patients with psoriasis were more likely to have a history of psychiatric disorders (36.6{\%} vs. 13.2{\%} χ 2 (1) = 9.55; p = 0.002) compared to patients with allergies. Specifically, patients with psoriasis more likely had a diagnosis of a mood disorder (16.1{\%} vs. 3.9{\%} χ 2 (1) = 6.85; p = 0.009; 16.1{\%} vs. 0{\%} χ 2 (1) = 9.56; p = 0.002) and reported past suicidal ideation (33.9{\%} vs. 15.6{\%} χ 2 (1) = 7.89; p = 0.005; 33.9{\%} vs. 18.9{\%} χ 2 (1) = 3.96; p = 0.047) as compared to those with melanoma and allergy. Conclusions: The results from this study suggest that patients affected by psoriasis have an increased risk of psychiatric comorbidities and suicidal ideation compared to those who have other dermatological disorders.",
keywords = "anxiety, comorbidity, depression, dermatological disorders, Psoriasis, psychiatry, suicide risk",
author = "Maurizio Pompili and Marco Innamorati and Alberto Forte and Denise Erbuto and Lamis, {Dorian A.} and Alessandra Narcisi and Claudia Rea and Diego Orsini and Andrea D’Arino and Annalisa Arcese and Samantha Bellini and Sara Trovarelli and Gianluca Serafini and Mario Amore and Antonio Costanzo and Paolo Girardi",
year = "2017",
month = "7",
day = "3",
doi = "10.1080/13651501.2017.1301482",
language = "English",
volume = "21",
pages = "209--214",
journal = "International Journal of Psychiatry in Clinical Practice",
issn = "1365-1501",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Psychiatric comorbidity and suicidal ideation in psoriasis, melanoma and allergic disorders

AU - Pompili, Maurizio

AU - Innamorati, Marco

AU - Forte, Alberto

AU - Erbuto, Denise

AU - Lamis, Dorian A.

AU - Narcisi, Alessandra

AU - Rea, Claudia

AU - Orsini, Diego

AU - D’Arino, Andrea

AU - Arcese, Annalisa

AU - Bellini, Samantha

AU - Trovarelli, Sara

AU - Serafini, Gianluca

AU - Amore, Mario

AU - Costanzo, Antonio

AU - Girardi, Paolo

PY - 2017/7/3

Y1 - 2017/7/3

N2 - © 2017 Informa UK Limited, trading as Taylor & Francis Group. Objective: Psychiatric disorders and suicide risk (especially in psoriasis) are frequent and disabling conditions in patients with skin diseases. The aim of this study was to examine the risk of suicide and stressful life events in a sample of patients with skin disease. Methods: A sample of 242 dermatological patients (142 women and 100 men), 112 of which had psoriasis, 77 had melanoma, and 53 were suffering with chronic allergic diseases. Patients were administered the MINI International Neuropsychiatric Interview (MINI), Hamilton Depression Rating Scale (HDRS), Hamilton Anxiety Rating Scale (HARS), and the Columbia-Suicide Severity Rating Scale (C-SSRS). Patients were also asked about their experiences with stressful life events. Results: Patients with psoriasis were more likely to have a history of psychiatric disorders (36.6% vs. 13.2% χ 2 (1) = 9.55; p = 0.002) compared to patients with allergies. Specifically, patients with psoriasis more likely had a diagnosis of a mood disorder (16.1% vs. 3.9% χ 2 (1) = 6.85; p = 0.009; 16.1% vs. 0% χ 2 (1) = 9.56; p = 0.002) and reported past suicidal ideation (33.9% vs. 15.6% χ 2 (1) = 7.89; p = 0.005; 33.9% vs. 18.9% χ 2 (1) = 3.96; p = 0.047) as compared to those with melanoma and allergy. Conclusions: The results from this study suggest that patients affected by psoriasis have an increased risk of psychiatric comorbidities and suicidal ideation compared to those who have other dermatological disorders.

AB - © 2017 Informa UK Limited, trading as Taylor & Francis Group. Objective: Psychiatric disorders and suicide risk (especially in psoriasis) are frequent and disabling conditions in patients with skin diseases. The aim of this study was to examine the risk of suicide and stressful life events in a sample of patients with skin disease. Methods: A sample of 242 dermatological patients (142 women and 100 men), 112 of which had psoriasis, 77 had melanoma, and 53 were suffering with chronic allergic diseases. Patients were administered the MINI International Neuropsychiatric Interview (MINI), Hamilton Depression Rating Scale (HDRS), Hamilton Anxiety Rating Scale (HARS), and the Columbia-Suicide Severity Rating Scale (C-SSRS). Patients were also asked about their experiences with stressful life events. Results: Patients with psoriasis were more likely to have a history of psychiatric disorders (36.6% vs. 13.2% χ 2 (1) = 9.55; p = 0.002) compared to patients with allergies. Specifically, patients with psoriasis more likely had a diagnosis of a mood disorder (16.1% vs. 3.9% χ 2 (1) = 6.85; p = 0.009; 16.1% vs. 0% χ 2 (1) = 9.56; p = 0.002) and reported past suicidal ideation (33.9% vs. 15.6% χ 2 (1) = 7.89; p = 0.005; 33.9% vs. 18.9% χ 2 (1) = 3.96; p = 0.047) as compared to those with melanoma and allergy. Conclusions: The results from this study suggest that patients affected by psoriasis have an increased risk of psychiatric comorbidities and suicidal ideation compared to those who have other dermatological disorders.

KW - anxiety

KW - comorbidity

KW - depression

KW - dermatological disorders

KW - Psoriasis

KW - psychiatry

KW - suicide risk

UR - http://www.scopus.com/inward/record.url?scp=85015826930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015826930&partnerID=8YFLogxK

U2 - 10.1080/13651501.2017.1301482

DO - 10.1080/13651501.2017.1301482

M3 - Article

AN - SCOPUS:85015826930

VL - 21

SP - 209

EP - 214

JO - International Journal of Psychiatry in Clinical Practice

JF - International Journal of Psychiatry in Clinical Practice

SN - 1365-1501

IS - 3

ER -